期刊文献+

一例牛魏氏梭菌和化脓隐秘杆菌混合感染的实验室诊断 被引量:1

Laboratory diagnosis of a mixed infection of Clostridium bovis and Trueperella Pyogenes
下载PDF
导出
摘要 2019年8月,在黑龙江省黑河市嫩江某一牛场中出现了大批牛死亡现象,其病死牛主要表现为气性坏疽、化脓感染,并且全身实质器官有明显出血等特征。经统计发病率为30%,病死率为90%。结合流行病学资料分析临床症状、病理变化和实验室诊断,病料为剖检后当日死亡且病理变化明显的病死牛,确诊为牛魏氏梭菌和牛化脓隐秘杆菌引起的混合感染。在对分离出的细菌进行药敏试验时发现,产生耐药性的药物有恩诺沙星、硫酸庆大霉素、盐酸林可霉素、链霉素。 In August 2019, a large number of cattle died in a cattle farm in Nenjiang, Heihe City, Heilongjiang Province. The diseased and dead cattle were mainly manifested as gas gangrene,purulent infection, and significant bleeding in the parenchyma of the whole body. The statistical incidence is 30%, and the fatality rate is 90%. The clinical symptoms, pathological changes, and laboratory diagnosis were analyzed based on epidemiological data. The disease material was dead cows that died on the day after autopsy and had obvious pathological changes. The diagnosis was a mixed infection caused by Clostridium bovis and Cryptococcus bovis. During the susceptibility test of the isolated bacteria, it was found that the drugs that produced resistance were enrofloxacin, gentamicin sulfate, lincomycin hydrochloride, and streptomycin.
作者 王维 李虎丹 倪宏波 Wang Wei;Li Hudan;Ni Hongbo(College of animal science and technology,Heilongjiang Bayi Agricultural University,Heilongjiang Daqing 163000)
出处 《现代畜牧兽医》 2020年第3期39-43,共5页 Modern Journal of Animal Husbandry and Veterinary Medicine
关键词 牛魏氏梭菌 隐秘杆菌 混合感染 药敏试验 Clostridium bovis Trueperella Pyogenes Mixed infection Drug sensitivity test
  • 相关文献

参考文献7

二级参考文献44

  • 1车发梅,河生德,铁富萍.牦牛魏氏梭菌和巴氏杆菌混合感染的诊治[J].畜牧与兽医,2010,42(6):110-111. 被引量:5
  • 2李云霄,金鑫,张营,单雪梅,于丹.魏氏梭菌病诊断方法研究进展[J].动物医学进展,2007,28(7):88-93. 被引量:31
  • 3HELEN B J, STEPHEN J B. Arcanobacterium pyogenes: molecular pathogenesis of an animal opportunist [ J ]. Antonie Van Leeuwen- hoek, 2005, 88:87-102.
  • 4BILLINGTON S J, SONGER J G, JOST B H. Widespread distribution of a Tet W determinant among tetracycline resistant isolates of the animal pathogen, Arcanobacterium pyogenes[ J]. Antimicrob A- gents Chemother,2002a, 46 : 1281 - 1287.
  • 5TRINH H T, BILLINGTON S J, FIELD A C, et al. Susceptibility of Arcanobacterium pyogenes to tetracyclines, macrolides and lincosamides[J]. Vet Microbiol, 2002, 85:353-359.
  • 6BILLINGTON S J, JOST B H, CUEVAS W A, et al. The Arcanobacterium ( Actinomyces ) pyogenes hemolysin, pyolysin, is a novel member of the thiolactivated cytolysin family [ J ]. J Bacteriol, 1997, 179:6100 -6106.
  • 7NARAYANAN S, NAGARAJA T G, WALLACE N, et al. Biochemical and ribotypie comparison of Actinomyces pyogenes and A. pyogenes-like organisms from liver abscesses, ruminal wall, and rumina/contents of cattle[J]. Am J Vet Res, 1998, 59:271 - 276.
  • 8Caoman R J. Rev Med Microbiol,1997,8:43-45.
  • 9Billington S J, et al. Infect Immun, 1998,66:4531-4536.
  • 10Hardy S P, et al. Med Microbiol,1999,48:235-243.

共引文献47

同被引文献29

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部